Reports Outline Pancreatic Cancer Study Results from University of Florida (Impact of Medicaid Expansion On Stage At Diagnosis for Us Adults With Pancreatic Cancer: a Population-based Study): Oncology – Pancreatic Cancer

2023 FEB 06 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Fresh data on Oncology - Pancreatic Cancer are presented in a new report. According to news reporting from Jacksonville, Florida, by NewsRx journalists, research stated, “We evaluated whether Medicaid expansion is associated with earlier stage at diagnosis for pancreatic cancer taking into account key demographic, clinical, and geographic factors. We obtained Surveillance, Epidemiology, and End-Results (SEER-18) data on individuals diagnosed with pancreatic cancer from 2007 to 2016 (< 65 years of age).”

Financial supporters for this research include Scott R. MacKenzie Foundation, National Institutes of Health, National Institute on Aging internal career development award at the University of Florida College of Medicine Jacksonville.

The news correspondents obtained a quote from the research from the University of Florida, “We defined non-metastatic as either local or regional disease (vs. metastatic disease). To estimate the association of Medicaid expansion with pancreatic cancer stage at diagnosis, we used a difference-in-differences model, at the individual level, comparing those from early-adopting states in 2014 to non-early-adopting states. We utilized cluster-robust standard errors and explored the role of demographic factors (race, sex, insurance at diagnosis), clinical indicator (disease in the head of the pancreas), and county characteristics (Urban Influence Code, Social Deprivation Index). In the univariable setting, the probability of non-metastatic disease at diagnosis increased by 3.9 percentage points (ppt) for those from Medicaid expansion states post-expansion (n = 36,609). After adjustment for covariates, the ppt was attenuated to 2.7. Of particular note, we observed evidence of interactions with sex and race. The beneficial effect was less pronounced for men (increase in the probability of non-metastatic stage at diagnosis by 2.1ppt) than women (3.6ppt) and non-existent for blacks (- 3.1ppt) compared to whites (4.9ppt) and other races (4.8ppt). Medicaid expansion is associated with increased probability of non-metastatic stage at diagnosis for pancreatic cancer; however, this beneficial effect is not uniform across sex and race.”

According to the news reporters, the research concluded: “This underscores the need to investigate the impact of policy and implementation strategies on pancreatic cancer survival disparities.”

This research has been peer-reviewed.

For more information on this research see: Impact of Medicaid Expansion On Stage At Diagnosis for Us Adults With Pancreatic Cancer: a Population-based Study. Journal of Racial and Ethnic Health Disparities, 2023. Journal of Racial and Ethnic Health Disparities can be contacted at: Springer Int Publ Ag, Gewerbestrasse 11, Cham, Ch-6330, Switzerland.

Our news journalists report that additional information may be obtained by contacting Erin M. M. Mobley, University of Florida, College of Medicine, Dept. of Surgery, Division of General Surgery and Surgical Oncology, Jacksonville, FL 32209, United States. Additional authors for this research include Keouna Pather, Ziad T. T. Awad, Michael S. S. Gutter, Dejana Braithwaite, Alexander S. S. Parker, Christina Guerrier, Ian Tfirn, Kim Vigal, Mochamad M. M. Nataliansyah, Susan Tsai and Brett Baskovich.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s40615-022-01459-4. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)